What were some of the most distinctive healthcare and medtech innovations from Taiwan showcased at Medical Fair Asia 202...
Which industries and applications will be the primary beneficiaries of the resins manufactured in Quzhou? The primary b...
How do you see the relationship between Tenthpin's India Innovation Hub and its established Japan operations, particular...
How do you view the multiple myeloma market in APAC, addressing its affordability and accessibility? Asia Pacific is at...
Avantor India has been appointed the exclusive distributor of Parafilm M in India, a product that is almost ubiquitous i...
In New Delhi in May 2026, the Australian High Commissioner hosted a Health Leaders Roundtable convened with the Australi...
Tenthpin has positioned Bengaluru as both an innovation and delivery hub. What does this mean in practical terms, and wh...
The latest personalised mRNA cancer vaccine data have renewed attention on individualized oncology. How significant is t...
As Asia-Pacific’s manufacturing landscape becomes more sophisticated, purification and separation technolo...
Federal Express Corporation has completed its inaugural Frederick W. Smith Day of Service across Asia Pacific, bringing ...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult cancers to treat, creating an urgent need for ...
Isotope analysis is moving beyond specialised laboratories towards broader, molecular-level applications. In this BioSpe...
China’s biotech and pharmaceutical sector is entering a new phase of global relevance. A surge in out-licensing de...
How is Takeda’s partnership with Biological E. Limited playing a role in strengthening dengue vaccine access in In...
As cell therapies advance towards greater clinical sophistication and commercial scale, the focus is shifting fr...
In conversation with BioSpectrum Asia, Laurie Masiello and John Masiello, Co-Founders of Predictive Monitor, explore how...
Australia is rapidly evolving beyond its reputation as a destination for early-stage clinical trials to build a more com...
How are Australia–India health partnerships driving innovations in the non-communicable diseases sector? We have ...
For decades, cancer treatment has largely focused on finding a single breakthrough therapy capable o...
J-Pharma has built its pipeline around amino acid transporter (LAT1)-targeted therapies. What was the vision behind this...
RESILIA tissue has been positioned as a significant advancement in valve technology. How does RESILIA tissue differ from...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
Africa carries the majority of the global sickle cell disease burden, yet care across many health systems remains fragme...
The next generation of cell and gene therapies is pushing manufacturing beyond the limits of conventiona...
Exosomes are rapidly emerging as one of the most promising frontiers in regenerative medicine, offering the therapeutic ...
